Invention Application
- Patent Title: MODULATION OF BCL2-ASSOCIATED ATHANOGENE EXPRESSION
- Patent Title (中): 调节BCL2相关的ATH表达
-
Application No.: PCT/US2003/037237Application Date: 2003-11-21
-
Publication No.: WO2004047736A2Publication Date: 2004-06-10
- Inventor: BENNETT, Frank, C. , DEAN, Nicholas, M. , DOBIE, Kenneth, W.
- Applicant: ISIS PHARMACEUTICALS, INC. , BENNETT, Frank, C. , DEAN, Nicholas, M. , DOBIE, Kenneth, W.
- Applicant Address: 2292 Faraday Avenue, Carlsbad, CA 92008 US
- Assignee: ISIS PHARMACEUTICALS, INC.,BENNETT, Frank, C.,DEAN, Nicholas, M.,DOBIE, Kenneth, W.
- Current Assignee: ISIS PHARMACEUTICALS, INC.,BENNETT, Frank, C.,DEAN, Nicholas, M.,DOBIE, Kenneth, W.
- Current Assignee Address: 2292 Faraday Avenue, Carlsbad, CA 92008 US
- Agency: CALDWELL, John, W.
- Priority: US10/304,105 20021121
- Main IPC: A61K
- IPC: A61K
Abstract:
Compounds, compositions and methods are provided for modulating the expression of BCL2-associated athanogene. The compositions comprise oligonucleotides, targeted to nucleic acid encoding BCL2-associated athanogene. Methods of using these compounds for modulation of BCL2-associated athanogene expression and for diagnosis and treatment of disease associated with expression of BCL2-associated athanogene are provided.
Information query
